Treatment with fibrates is associated with higher LAL activity in dyslipidemic patients.

Pavanello, Chiara; Baragetti, Andrea; Branchi, Adriana; Grigore, Liliana; Castelnuovo, Samuela; Giorgio, Eleonora; Catapano, Alberico L; Calabresi, Laura; Gomaraschi, Monica.
Pharmacol Res; 147: 104362, 2019 Jul 19.
Artigo em Inglês | MEDLINE | ID: mdl-31330253